Ortenau Klinikum


Hospital

Location:
Achern, u.a., Germany


Publications in cooperation with FAU scientists


Schneeweiss, A., Moebus, V., Tesch, H., Hanusch, C., Denkert, C., Luebbe, K.,... Loibl, S. (2019). Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial. European journal of cancer, 106, 181-192. https://dx.doi.org/10.1016/j.ejca.2018.10.015
Hillemanns, P., Friese, K., Dannecker, C., Klug, S., Seifert, U., Iftner, T.,... Jentschke, M. (2019). Prevention of Cervical Cancer. Geburtshilfe und Frauenheilkunde, 79(2), 160-175. https://dx.doi.org/10.1055/a-0828-7722
Woeckel, A., Festl, J., Stueber, T., Brust, K., Stangl, S., Heuschmann, P.U.,... Krockenberger, M. (2018). Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer. Geburtshilfe und Frauenheilkunde, 78(10), 927-948. https://dx.doi.org/10.1055/a-0646-4522
Woeckel, A., Festl, J., Stueber, T., Brust, K., Krockenberger, M., Heuschmann, P.U.,... Stangl, S. (2018). Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe und Frauenheilkunde, 78(11), 1056-1088. https://dx.doi.org/10.1055/a-0646-4630
Hack, C., Fasching, P., Fehm, T., De Waal, J., Rezai, M., Baier, B.,... Paepke, D. (2017). Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study. Integrative Cancer Therapies, 16(2), 165-175. https://dx.doi.org/10.1177/1534735416668575
Gaß, P., Fasching, P., Fehm, T., De Waal, J., Rezai, M., Baier, B.,... Löhberg, C. (2016). Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study. Breast Care, 11(5), 315-322. https://dx.doi.org/10.1159/000452468
Wolfsgruber, S., Jessen, F., Koppara, A., Kleineidam, L., Schmidtke, K., Froelich, L.,... Wagner, M. (2015). Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI. Neurology, 84(12), 1261-8. https://dx.doi.org/10.1212/WNL.0000000000001399
Wolfsgruber, S., Wagner, M., Schmidtke, K., Froelich, L., Kurz, A., Schulz, S.,... Jessen, F. (2014). Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment. PLoS ONE, 9(7), e100812. https://dx.doi.org/10.1371/journal.pone.0100812
Ekici, A.B., Hackenbeck, T., Moriniere, V., Panness, A., Büttner, M., Uebe, S.,... Wiesener, M.S. (2014). Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney International, 86(3), 589-99. https://dx.doi.org/10.1038/ki.2014.72

Last updated on 2017-08-03 at 14:16